International Patent: SELF-CLEAVABLE RIBOZYME THERAPEUTIC NUCLEIC ACID MOLECULES

GENEVA, June 26 -- MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V. filed a patent application (EP2025/085643) for “SELF-CLEAVABLE RIBOZYME THERAPEUTIC NUCLEIC ACID MOLECULES”. With publication no. WO/2026/120132, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 15/113

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....